Deals
Soon-Shiong’s NantKwest Climbs as $207 Million Raised in IPO
This article is for subscribers only.
NantKwest Inc., a cancer drugmaker headed by billionaire Patrick Soon-Shiong, gained in its trading debut after raising $207 million in a larger-than-expected initial public offering.
The shares rose 39 percent to $34.64 at the close in New York, valuing the company at $3.67 billion. NantKwest offered